Sign in
4

Changes in Ownership

Tyra Biosciences, Inc. Filed Acc 0000950170-25-011737

Options or other derivatives

  • Director acquired 37,200 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Gulfo Adele M. Director 2025-01-29 Grant or award · Common Stock (Right to Buy) +37,200 37,200 D: show line 1 in the form
Loading xslF345X05/ownership.xml…